1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Aptevo Therapeutics Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2016

Location

Seattle WA US

Primary Industry

Biotechnology

About

Founded in 2016 and based in Washington, US, Aptevo Therapeutics Inc. is a biotechnology company primarily focused on bringing novel oncology and hematology therapeutics to market in the United States.
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Oncology/Cancer Treatment
Website
www.aptevotherapeutics.com
Total Amount Raised
Subscriber access only

Deals

Deals Type
Private Debt
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Aptevo Therapeutics Inc. 04 Aug 2016
Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.